Tom Johnson
LifeSci Advisors
Replay available
PDS Biotechnology Corporation (PDSB) Q4 2024 Earnings Call
PDS Biotechnology Corporation (NASDAQ: PDSB) Q4 2024 earnings conference call, held 2025-03-27. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Frank Beto-Addo
Chief Executive Officer
Lars Bostar
Chief Financial Officer
Dr. Kirk Shepherd
Chief Medical Officer
Joe Pankinas
Analyst, HC Wainwright
Mayank Montani
Analyst, B-Riley Securities
James Malloy
Analyst, Alliance Global Partners
Unnamed Analyst
Analyst (Follow-up)
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Pds Biotechnology Corporation.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.236 Good morning, and welcome to PDS Biotech's fourth quarter and full year of 2024 earnings 00:00:04.236 -- 00:00:08.921 conference call. At this time, all participants are currently in listen-only mode. 00:00:08.921 -- 00:00:13.806 Following the formal presentation, we'll open the call up for a question and answer session. 00:00:13.806 -- 00:00:18.752 At this time, I would now like to turn the conference over to Tom Johnson, LifeSci Advisors. 00:00:18.752 -- 00:00:21.294 Please go ahead, sir. 00:00:21.294 -- 00:00:26.660 Thank you, operator. Good morning, everyone, and welcome to PDS Biotech's 2024 results 00:00:26.660 -- 00:00:30.748 and clinical program update call. I'm joined in the call today by the following members 00:00:30.748 -- 00:00:35.173 of the company's management team. Dr. Frank Beto-Addo, Chief Executive Officer, Dr. 00:00:35.173 -- 00:00:40.099 Kirk Shepherd, Chief Medical Officer, and Lars Bostar, Chief Financial Officer. 00:00:40.099 -- 00:00:44.044 Dr. Beto-Addo will begin with an overview of the company's recent progress in its clinical 00:00:44.044 -- 00:00:49.831 development program. Mr. Bostar will review the financial results for the 2024 fiscal 00:00:49.831 -- 00:00:53.855 year. And Dr. Shepard will then join the call to help address questions from covering 00:00:53.855 -- 00:00:55.381 analysts. 00:00:55.381 -- 00:00:59.284 As a reminder, during this call, we will make forward-looking statements, which are subject 00:00:59.284 -- 00:01:03.408 to various risks and uncertainties that could cause our actual results to differ materially 00:01:03.408 -- 00:01:08.052 from these statements. Any such statements should be considered in conjunction with cautionary 00:01:08.052 -- 00:01:12.416 statements in our press re...